Recent debates about drug pricing have tended to focus on manufacturers and patients, but Doug Collins is among the few legislators looking at the middlemen.
Collins, a Republican congressman from Georgia, railed against the country’s three major pharmacy benefit managers in an interview with STAT, expressing his desire for a drug-pricing debate that centers on what he views as the true power centers instead of “Pharma bro” and the push to allow drug-price negotiation under Medicare Part D.
Express Scripts, UnitedHealth, and CVS Health collectively control roughly 80 percent of the market, which Collins says has squeezed out community pharmacists and obscured many of the factors leading to prices that patients end up paying.
About the Author Reprints
